← back to search

David Forman

University of Leeds · GB
Area of research
Surgery · Oncology
Research interest
Research interests include Helicobacter pylori-related gastroenterology studies, Global Cancer Incidence and Screening, Gastric Cancer Management and Outcomes, and Gastroesophageal reflux and treatments.
h-index
77
citations
132,067
works
241
NIH funding
primary concept
email

Recent publications

<i>Helicobacter pylori</i> Screen-and-Treat Programs for Gastric Cancer Prevention — IARC Working Group Report
New England Journal of Medicine 2026cited by 1position: lastdoi
Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035
Gut 2020cited by 485position: middledoi
Tobacco-related cancers in Europe: The scale of the epidemic in 2018
European Journal of Cancer 2020cited by 51position: middledoi
Cancer Prevention Europe
Molecular Oncology 2019cited by 90position: middledoi
Discovery of common and rare genetic risk variants for colorectal cancer
Nature Genetics 2018cited by 600position: middledoi
Epidemiology of Helicobacter pylori and CagA-Positive Infections and Global Variations in Gastric Cancer
Toxins 2018cited by 164position: middledoi
Time for a European initiative for research to prevent cancer: A manifesto for Cancer Prevention Europe (CPE)
Journal of Cancer Policy 2018cited by 42position: firstdoi
Interaction between polymorphisms in aspirin metabolic pathways, regular aspirin use and colorectal cancer risk: A case-control study in unselected white European populations
PLoS ONE 2018cited by 32position: middledoi
Eradication therapy for peptic ulcer disease in <i>Helicobacter pylori</i> -positive people
Cochrane Database of Systematic Reviews 2016cited by 263position: middledoi
Recurrent Coding Sequence Variation Explains Only A Small Fraction of the Genetic Architecture of Colorectal Cancer
Scientific Reports 2015cited by 25position: middledoi
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
International Journal of Cancer 2014cited by 29,014position: middledoi
Comprehensive Control of Human Papillomavirus Infections and Related Diseases
Vaccine 2013cited by 439position: middledoi
Comprehensive Control of Human Papillomavirus Infections and Related Diseases
Vaccine 2013cited by 331position: middledoi
Testicular cancer incidence to rise by 25% by 2025 in Europe? Model-based predictions in 40 countries using population-based registry data
European Journal of Cancer 2013cited by 166position: middledoi
Comprehensive Control of Human Papillomavirus Infections and Related Diseases
Vaccine 2013cited by 98position: middledoi
Comprehensive Control of Human Papillomavirus Infections and Related Diseases
Vaccine 2013cited by 43position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 3 papers (2018–2020)Linda Bauld · University of Edinburgh3 papers (2018–2020)Hans H. Storm · London Cancer3 papers (2018–2020)Isabelle Soerjomataram · World Health Organization3 papers (2014–2020)Hermann Brenner · Stanford University3 papers (2018–2020)Ellen Kampman · University of Virginia2 papers (2018–2019)Joakim Dillner · Regional Cancer Center2 papers (2018–2019)Joachim Schüz · World Health Organization - Lyon Office2 papers (2013–2019)Christopher P. Wild · University of Sheffield2 papers (2018–2019)Karen Brown · University of Leicester2 papers (2018–2019)Freddie Bray · Centre National de la Recherche Scientifique2 papers (2013–2014)Bernardo Bonanni · European Institute of Oncology2 papers (2018–2019)Karen Steindorf · Charité - Universitätsmedizin Berlin2 papers (2018–2019) · 2 papers (2018–2020)Emma Northwood · Institute of Genetics and Cancer1 papers (2018–2018)Aude Fléchon · Lymphoma Study Association1 papers (2013–2013)M. Constanza Camargo · National Institutes of Health1 papers (2020–2020)Joannie Lortet‐Tieulent · San Francisco VA Medical Center1 papers (2013–2013)Béatrice Fervers · Inserm1 papers (2013–2013)Cornelia M. Ulrich · University of Utah1 papers (2018–2018)